The ADC binds HER2 (not topoisomerase I), is internalized, and releases a camptothecin payload that inhibits topoisomerase I to cause DNA damage and apoptosis. Expression of topoisomerase I alone does not direct killing; only HER2-targeted delivery (with possible bystander effect) leads to cytotoxicity.